Steward Partners Investment Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Hold
1,473
﹤0.01% 2152
2025
Q4
$152K Sell
1,473
-15,500
-91% -$1.51M ﹤0.01% 2076
2025
Q3
$1.53M Buy
16,973
+812
+5% +$71.1K 0.01% 875
2025
Q2
$1.42M Hold
16,161
0.01% 838
2025
Q1
$1.47M Sell
16,161
-5,577
-26% -$502K 0.01% 774
2024
Q4
$1.88M Buy
21,738
+14,908
+218% +$1.35M 0.02% 663
2024
Q3
$649K Buy
6,830
+504
+8% +$47.9K 0.01% 1009
2024
Q2
$579K Sell
6,326
-145
-2% -$12.9K 0.01% 1002
2024
Q1
$587K Sell
6,471
-825
-11% -$72.2K 0.01% 991
2023
Q4
$594K Buy
7,296
+185
+3% +$14.5K 0.01% 923
2023
Q3
$568K Sell
7,111
-2,006
-22% -$162K 0.01% 876
2023
Q2
$718K Buy
9,117
+9,037
+11,296% +$707K 0.01% 806
2023
Q1
$6.21K Hold
80
﹤0.01% 2711
2022
Q4
$6.22K Hold
80
﹤0.01% 2690
2022
Q3
$5K Hold
80
﹤0.01% 2778
2022
Q2
$6K Hold
80
﹤0.01% 2710
2022
Q1
$6K Hold
80
﹤0.01% 2842
2021
Q4
$6K Hold
80
﹤0.01% 2778
2021
Q3
$6K Hold
80
﹤0.01% 2764
2021
Q2
$6K Hold
80
﹤0.01% 6441
2021
Q1
$5.52K Hold
80
﹤0.01% 2988
2020
Q4
$5K Hold
80
﹤0.01% 2525
2020
Q3
$5K Buy
+80
New +$5.06K ﹤0.01% 2380

Other funds holding PPH

Steward Partners Investment Advisory's PPH Position: Q1 2026 in Review

Steward Partners Investment Advisory held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 1,473 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2152.

Steward Partners Investment Advisory first reported a position in PPH in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.88M in Q4 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Steward Partners Investment Advisory held 1,473 shares of VanEck Pharmaceutical ETF worth $153K as of Q1 2026.
  • Steward Partners Investment Advisory left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2152 holding.
  • Steward Partners Investment Advisory first reported a position in VanEck Pharmaceutical ETF in Q3 2020 and has held it in 23 quarters since.
  • Steward Partners Investment Advisory's VanEck Pharmaceutical ETF position peaked at $1.88M in Q4 2024.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.